![PDF) Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study PDF) Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study](https://i1.rgstatic.net/publication/313023952_Comparison_of_the_Efficacy_and_Safety_of_Aripiprazole_Versus_Bupropion_Augmentation_in_Patients_With_Major_Depressive_Disorder_Unresponsive_to_Selective_Serotonin_Reuptake_Inhibitors_A_Randomized_Pros/links/5f3c5025299bf13404ced016/largepreview.png)
PDF) Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study
Full article: Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice
![Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression – Washington University School of Medicine in St. Louis Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/Lenze-pills.jpg)